Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...] …
Category: Providers
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.S. senator introduced a bill to extend 340B eligibility to certain outpatient rural hospitals with emergency services, mirroring a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The health center advocacy group behind a proposed 340B program alternative recently slammed the 340B ACCESS Act, saying the newly [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A leading Virginia health center advocate published an op-ed late last week blasting Gov. Glenn Youngkin (R) for choosing “Big [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Canadian drugmaker Bausch & Lomb announced last week that, beginning July 1, it will no longer offer 340B discounted products [...] …
